Response of specific skin hypersensitivity and haemagglutination inhibiting antibody after smallpox vaccination in human newborns and adults.
D000328:Adult; D000367:Age Factors; D000906:Antibodies / Q000032:analysis*; D001768:Blister / Q000209:etiology; D001769:Blood; D002648:Child; D002921:Cicatrix / Q000209:etiology; D005260:Female; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology*; D007111:Immunity, Cellular; D005779:Immunodiffusion; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007194:India; D007223:Infant; D007231:Infant, Newborn; D008722:Methods; D011247:Pregnancy; D012899:Smallpox / Q000517:prevention & control*; D013997:Time Factors; D014374:Tuberculin Test; D014470:Umbilical Cord; D014611:Vaccination / Q000009:adverse effects*; D012901:Variola virus / Q000276:immunology*
D000906:Antibodies; D007074:Immunoglobulin G; D007075:Immunoglobulin M